PE20110206A1 - Derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents

Derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Info

Publication number
PE20110206A1
PE20110206A1 PE2010000465A PE2010000465A PE20110206A1 PE 20110206 A1 PE20110206 A1 PE 20110206A1 PE 2010000465 A PE2010000465 A PE 2010000465A PE 2010000465 A PE2010000465 A PE 2010000465A PE 20110206 A1 PE20110206 A1 PE 20110206A1
Authority
PE
Peru
Prior art keywords
diona
indol
dihydro
oxo
atoms
Prior art date
Application number
PE2010000465A
Other languages
English (en)
Inventor
Jean-Claude Ortuno
Jean-Michel Lacoste
Michael Burbridge
Alain Pierre
Alexis Cordi
Imre Fejes
John Hickman
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PE20110206A1 publication Critical patent/PE20110206A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Storage Device Security (AREA)
  • Computer And Data Communications (AREA)

Abstract

REFERIDA A UN DERIVADO DE DIHIDROINDOLONA DE FORMULA (I), DONDE m Y n SON 1 O 2; A ES PIRROLILO NO SUSTITUIDO O SUSTITUIDO POR 1 A 3 ALQUILO C1-C6 LINEALES O RAMIFICADOS; X ES C(O), S(O) O SO2; R1 Y R2 SON ALQUILO C1-C6 O JUNTO CON EL NITROGENO AL QUE ESTAN UNIDOS FORMAN UN HETEROCICLO MONO O BICICLICO DE 5 A 8 ATOMOS CON HETEROATOMOS TALES COMO N, O Y S; R3 Y R4 FORMAN JUNTO CON LOS ATOMOS A LOS QUE ESTAN UNIDOS UN HETEROCICLO MONO O BICICLICO DE 5 A 8 ATOMOS CON HETEROATOMOS TALES COMO N, O Y S; R5 ES H O ALQUILO C1-C6 LINEAL O RAMIFICADO; R6 ES H O HALOGENO. SON COMPUESTOS PREFERIDOS: 3-[(3-{[4-(4-MORFOLINILMETIL)-1H-PIRROL-2-IL]METILEN}-2-OXO-2,3-DIHIDRO-1H-INDOL-5-IL)METIL]-1,3-TIAZOLIDIN-2,4-DIONA, 3-[((3Z)-3-{[4-(4-MORFOLINILMETIL)-1H-PIRROL-2-IL]METILEN}-2-OXO-2,3-DIHIDRO-1H-INDOL-5-IL)METIL]-1,3-TIAZOLIDIN-2,4-DIONA, 3-[3-(4-MORFOLIN-4-ILMETIL-1H-PIRROL-2-ILMETILEN)-2-OXO-2,3-DIHIDRO-1H-INDOL-5-ILMETIL]-OXAZOLIDIN-2,4-DIONA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA MIGRACION DE CELULAS CANCEROSAS Y SON UTILES EN EL TRATAMIENTO DEL CANCER, PRINCIPALMENTE, EN TUMORES SOLIDOS METASTASICOS
PE2010000465A 2009-08-04 2010-07-21 Derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen PE20110206A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903839A FR2948940B1 (fr) 2009-08-04 2009-08-04 Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PE20110206A1 true PE20110206A1 (es) 2011-04-09

Family

ID=41796204

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2010000465A PE20110206A1 (es) 2009-08-04 2010-07-21 Derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen

Country Status (43)

Country Link
US (3) US8133889B2 (es)
EP (1) EP2281822B1 (es)
JP (2) JP5475588B2 (es)
KR (1) KR101309101B1 (es)
CN (1) CN101987848B (es)
AP (1) AP2756A (es)
AR (1) AR077510A1 (es)
AU (1) AU2010203305B2 (es)
BR (1) BRPI1003241A2 (es)
CA (1) CA2710224C (es)
CL (1) CL2010000804A1 (es)
CO (1) CO6320143A1 (es)
CU (1) CU23921B1 (es)
CY (1) CY1113914T1 (es)
DK (1) DK2281822T3 (es)
EA (1) EA019481B1 (es)
EC (1) ECSP10010380A (es)
ES (1) ES2403227T3 (es)
FR (1) FR2948940B1 (es)
GE (1) GEP20125548B (es)
HK (1) HK1155742A1 (es)
HN (1) HN2010001537A (es)
HR (1) HRP20130327T1 (es)
IL (1) IL207183A (es)
JO (1) JO2808B1 (es)
MA (1) MA32184B1 (es)
ME (1) ME01491B (es)
MX (1) MX2010008557A (es)
MY (1) MY183326A (es)
NI (1) NI201000134A (es)
NZ (1) NZ586993A (es)
PE (1) PE20110206A1 (es)
PL (1) PL2281822T3 (es)
PT (1) PT2281822E (es)
RS (1) RS52701B (es)
SA (1) SA110310634B1 (es)
SG (1) SG168499A1 (es)
SI (1) SI2281822T1 (es)
TW (1) TWI408138B (es)
UA (1) UA105357C2 (es)
UY (1) UY32801A (es)
WO (1) WO2011015728A1 (es)
ZA (1) ZA201005424B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008411B1 (fr) * 2013-07-12 2015-07-03 Servier Lab Nouveau sel de la 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, sa preparation, et les formulations qui le contiennent
US10245270B2 (en) * 2013-07-12 2019-04-02 Les Laboratoires Servier Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr
US10343991B2 (en) * 2016-11-02 2019-07-09 Council Of Scientific & Industrial Research C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
CN113845524B (zh) * 2021-10-29 2023-11-07 四川农业大学 一种螺吡咯吲哚酮类化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892248A (ja) * 1994-09-26 1996-04-09 Yamanouchi Pharmaceut Co Ltd インドリノン誘導体
CA2383623A1 (en) * 1998-08-04 2000-02-17 Sugen, Inc. 3-methylidenyl-2-indolinone modulators of protein kinase
PT1157019E (pt) * 1998-12-17 2003-06-30 Hoffmann La Roche 4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2
EP1194539A2 (en) 1999-06-25 2002-04-10 Universität Zürich Hetero-associating coiled-coil peptides and screening method therefor
SK287142B6 (sk) * 2000-02-15 2010-01-07 Sugen, Inc. Inhibítory proteínkináz na báze pyrolom substituovaného 2-indolinónu, farmaceutický prípravok s ich obsahom a ich použitie
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
IL162203A0 (en) * 2001-12-27 2005-11-20 Theravance Inc Indolinone derivatives useful as protein inase inhibitors
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
RU2006117635A (ru) * 2003-10-24 2007-12-10 Шеринг Акциенгезельшафт (De) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
US7378530B2 (en) 2005-02-22 2008-05-27 Nereus Pharmaceuticals, Inc. Anti-cancer and anti-microbial 5-membered heterocyclic compounds
KR20080083341A (ko) * 2005-12-29 2008-09-17 더 스크립스 리서치 인스티튜트 인돌리논의 아미노산 유도체 기재의 단백질 키나제 억제제
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
US20120046287A1 (en) 2012-02-23
HN2010001537A (es) 2013-05-06
CA2710224A1 (fr) 2011-02-04
US8541412B2 (en) 2013-09-24
MX2010008557A (es) 2011-02-03
IL207183A (en) 2014-01-30
TWI408138B (zh) 2013-09-11
ME01491B (me) 2014-04-20
RS52701B (en) 2013-08-30
MA32184B1 (fr) 2011-04-01
MY183326A (en) 2021-02-18
CY1113914T1 (el) 2016-07-27
NZ586993A (en) 2012-01-12
AR077510A1 (es) 2011-08-31
US20130331380A1 (en) 2013-12-12
HRP20130327T1 (hr) 2013-05-31
FR2948940A1 (fr) 2011-02-11
CA2710224C (fr) 2013-01-08
CN101987848A (zh) 2011-03-23
JP2011037848A (ja) 2011-02-24
WO2011015728A1 (fr) 2011-02-10
TW201118092A (en) 2011-06-01
ECSP10010380A (es) 2011-03-31
GEP20125548B (en) 2012-05-25
CU23921B1 (es) 2013-07-31
UY32801A (es) 2011-01-31
UA105357C2 (uk) 2014-05-12
SG168499A1 (en) 2011-02-28
SI2281822T1 (sl) 2013-04-30
JP5475588B2 (ja) 2014-04-16
BRPI1003241A2 (pt) 2012-04-10
CU20100157A7 (es) 2012-03-15
HK1155742A1 (en) 2012-05-25
JP2013116908A (ja) 2013-06-13
US8133889B2 (en) 2012-03-13
EP2281822B1 (fr) 2013-01-16
EP2281822A1 (fr) 2011-02-09
DK2281822T3 (da) 2013-04-22
PT2281822E (pt) 2013-02-27
ES2403227T3 (es) 2013-05-16
CL2010000804A1 (es) 2011-08-26
PL2281822T3 (pl) 2013-06-28
FR2948940B1 (fr) 2011-07-22
KR101309101B1 (ko) 2013-09-16
US8653073B2 (en) 2014-02-18
AU2010203305B2 (en) 2015-02-05
CN101987848B (zh) 2014-06-18
SA110310634B1 (ar) 2013-11-10
AU2010203305A1 (en) 2011-02-24
JP5538580B2 (ja) 2014-07-02
JO2808B1 (en) 2014-09-15
AP2756A (en) 2013-09-30
KR20110014116A (ko) 2011-02-10
EA019481B1 (ru) 2014-04-30
IL207183A0 (en) 2010-12-30
CO6320143A1 (es) 2011-09-20
NI201000134A (es) 2014-02-11
ZA201005424B (en) 2011-04-28
EA201001087A1 (ru) 2011-04-29
US20110034460A1 (en) 2011-02-10
AP2010005343A0 (en) 2010-08-31

Similar Documents

Publication Publication Date Title
PE20110206A1 (es) Derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ECSP11011427A (es) Piperidinas sustituidas como antagonistas de ccr3.
TR201906123T4 (tr) P13 kinazı ve mtor inhibitörleri olarak triazin bileşikleri.
PE20090511A1 (es) Imidazopiridinonas
BR112014027143A2 (pt) pirrolobenzodiazepinas
SV2011003855A (es) Heteroarilos sustituidos
CY1115866T1 (el) Τριαζολοπυριμιδινες
MY159615A (en) Fused heterocyclic derivatives and methods of use as c-met inhibitors
PE20152033A1 (es) Heterociclos bicicliclos como inhibidores de fgfr
PE20161405A1 (es) Analogos de cortistatina y sintesis y usos de los mismos
PE20141205A1 (es) Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2
PE20160844A1 (es) Compuestos triciclicos como agentes anticancerigenos
UY31870A (es) Receptor metabotrópico de glutamato potenciadores 286
ECSP088871A (es) Derivados de triazolopirazina
UY30493A1 (es) Compuestos derivados 5-cloro-1??h,3h-espiro[ 1-benzofuran-2, 4??- piperidin]-1??-ilo sustituidos de los acidos acético y 2-metil- propanoico, composiciones farmacéuticas, procedimientos de preparacion y aplicaciones
PE20141685A1 (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmaceuticas de las mismas para el tratamiento de transtornos inflamatorios
AR086546A1 (es) Derivados de 7h-purin-8(9h)-ona como inhibidores de jak
EA201100161A1 (ru) Производные хинуклидина карбоната и их медицинские композиции
CO6700831A2 (es) Derivados de pirazina como bloqueadores de enac
EA201190017A1 (ru) Аминоэфирные производные алкалоидов и их медицинские композиции
PE20142186A1 (es) Derivados biciclicos de pirazinona
PE20151748A1 (es) Inhibidores de bace1
PE20160240A1 (es) Nuevos derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY32553A (es) Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos
PE20151060A1 (es) Nuevos derivados de pirazina como agonistas del receptor cb2

Legal Events

Date Code Title Description
FG Grant, registration